Novavax to seek US authorization of its coronavirus vaccine by the end of the year

Written by on November 6, 2021

"We'll have a file in the US hopefully before the end of the year," Erck said.

If the FDA gives the green light, the first 100 million doses of the protein-based vaccine will be ready to ship following authorization, Erck said.

Novavax's vaccine, called NVX-CoV2373, is made



Current track

Title

Artist